| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2014 | Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition. | Yen, CC; Hsiao, CD; Chen, WM; Wen, YS; Lin, YC; Chang, TW; Yao, FY; Hung, SC; Wang, JY; Chiu, JH; Wang, HW; Lin, CH; Chen, TH; Chen, PC; Liu, CL; Tzeng, CH; Fletcher, JA | OncoTargets and Therapy 5(3), 716-25 | | | |
| 2008 | Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome. | Chang, PM; Chen, PM; Hsieh, SL; Tzeng, CH; Liu, JH; Chiou, TJ; Wang, WS; Yen, CC; Gau, JP; Yang, MH | International journal of oncology 33(3), 549-54 | | | |
| 2013 | Expression of gremlin 1 correlates with increased angiogenesis and progression-free survival in patients with pancreatic neuroendocrine tumors | Chen, MH; Yeh, YC; Shyr, YM; Jan, YH; Chao, Y; Li, CP; Wang, SE; Tzeng, CH; Chang, PM; Liu, CY; Chen, MH; Hsiao, M; Huang, CY | J Gastroenterol Jan;48(1):101-108 | | | |
| 2007 | I branching formation in erythroid differentiation is regulated by transcription factor C/EBPα | Twu, YC; Chen, CP; Hsieh, CY; Tzeng, CH; Sun, CF; Wang, SH; Chang, MS ; Yu, LC | Blood 110(13), 4526-4534 | | | |
| 2012 | International Staging System predicts prognosis of Chinese patients with multiple myeloma across different calendar periods with application of novel agents. | Yang, SH; Teng, HW; Hong, YC; Liu, CY; Yu, YB; Yang, CF; Gau, JP; Liu, JH; Chang, TJ; Yen, JJ; Chen, PM; Chiou, TJ; Tzeng, CH; Hsiao, LT | Annals of hematology 91(1), 93-102 | | | |
| 2010 | Phosphorylation status of transcription factor C/EBPα determines cell surface poly-LacNAc branching (I antigen) formation in erythropoiesis and granulopoiesis | Twu, YH; Hsieh, CY; Lin, M; Tzeng, CH; Sun, CF; Yu, LC | Blood 115(12), 2491 - 2499 | | | |
